Keyphrases
Anti-glioblastoma
100%
Monensin
100%
Organoid Models
100%
Glioblastoma
100%
Cerebral Organoids
50%
Tumor Organoids
33%
Organoids
33%
IC50
33%
Ki-67
16%
U87 Cells
16%
PARP Expression
16%
Cortical Plate
16%
C-26
16%
Neural Stem Cells
16%
Tbr2
16%
Brain Organoids
16%
U87MG
16%
Analogue Compound
16%
Primary Malignant
16%
Ventricular System
16%
H2AX
16%
Proliferative Zone
16%
Patient Tumor
16%
Induced Pluripotent Stem Cells (iPSCs)
16%
Intermediate Zone
16%
Nestin
16%
Sex-determining Region Y-box 2 (SOX2)
16%
Glioblastoma Cells
16%
LC3-II
16%
Neural Rosettes
16%
Cell Viability Assay
16%
DNA Fragmentation
16%
Glycogen Synthase Kinase 3 (GSK3)
16%
Brain Development
16%
Clinical Outcomes
16%
Mini
16%
Anticancer Drugs
16%
Apoptotic Cell Death
16%
Phosphorylation
16%
Amides
16%
Days of Treatment
16%
Cell Migration
16%
Tumor Microenvironment
16%
Tuj1
16%
Cancer Types
16%
Median Survival
16%
Clinical Trials
16%
Cancer Cell Lines
16%
Tumor Size
16%
Drug Discovery
16%
Pharmacology, Toxicology and Pharmaceutical Science
Monensin
100%
Glioblastoma
100%
Malignant Neoplasm
100%
Neoplasm
50%
IC50
25%
Drug Discovery
25%
Carboxamide
12%
Tumor Microenvironment
12%
Nestin
12%
Anticarcinogen
12%
Microtubule Associated Protein 2
12%
Brain Cancer
12%
Clinical Trial
12%
Viability Assay
12%
Cell Viability
12%
Immunology and Microbiology
Organoid
100%
IC50
20%
Apoptosis
10%
Rosette Formation
10%
Neural Stem Cell
10%
Induced Pluripotent Stem Cell
10%
Tumor Volume
10%
Cancer Cell Line
10%
Cell Viability
10%
STAT3
10%
Cell Migration
10%
Autophagy
10%
DNA Fragmentation
10%
